Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma.
作者信息
Chiba Tetsuhiro, Kanai Fumihiko, Iwama Atsushi, Yokosuka Osamu
机构信息
Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; ; Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan;
出版信息
Hepatobiliary Surg Nutr. 2013 Feb;2(1):4-6. doi: 10.3978/j.issn.2304-3881.2012.09.02.
Abstract
摘要
相似文献
1
Circulating cancer stem cells: a novel prognostic predictor of hepatocellular carcinoma.
Hepatobiliary Surg Nutr. 2013 Feb;2(1):4-6. doi: 10.3978/j.issn.2304-3881.2012.09.02.
2
Cytotoxicity of Luffa cylindrica (L.) M.Roem. extract against circulating cancer stem cells in hepatocellular carcinoma.
J Ethnopharmacol. 2019 Jan 30;229:89-96. doi: 10.1016/j.jep.2018.09.034. Epub 2018 Oct 1.
3
Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis.
Acta Oncol. 2020 Jan;59(1):33-39. doi: 10.1080/0284186X.2019.1657940. Epub 2019 Sep 3.
4
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.
5
Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
BMC Cancer. 2016 Jul 20;16:506. doi: 10.1186/s12885-016-2526-4.
6
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
World J Gastroenterol. 2017 Aug 21;23(31):5650-5668. doi: 10.3748/wjg.v23.i31.5650.
7
Identification of Cancer Cell Stemness-Associated Long Noncoding RNAs for Predicting Prognosis of Patients with Hepatocellular Carcinoma.
DNA Cell Biol. 2021 Aug;40(8):1087-1100. doi: 10.1089/dna.2021.0282. Epub 2021 Jun 4.
8
Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
Tumori. 2014 Sep-Oct;100(5):536-40. doi: 10.1700/1660.18174.
9
Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
Dig Liver Dis. 2009 Dec;41(12):902-6. doi: 10.1016/j.dld.2009.04.013. Epub 2009 Jun 4.
10
Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma.
Cancers (Basel). 2020 Dec 18;12(12):3819. doi: 10.3390/cancers12123819.
引用本文的文献
1
Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications.
ACS Omega. 2023 Aug 9;8(33):30145-30157. doi: 10.1021/acsomega.3c02681. eCollection 2023 Aug 22.
2
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Cells. 2020 May 26;9(6):1331. doi: 10.3390/cells9061331.
3
Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells.
Mol Biol Rep. 2020 Apr;47(4):3065-3076. doi: 10.1007/s11033-020-05341-6. Epub 2020 Feb 28.
4
Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.
Syst Rev. 2017 Dec 19;6(1):262. doi: 10.1186/s13643-017-0660-y.
5
Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization.
Clin Transl Oncol. 2018 May;20(5):639-646. doi: 10.1007/s12094-017-1761-8. Epub 2017 Oct 11.
6
Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.
Oncotarget. 2017 May 22;8(37):61203-61214. doi: 10.18632/oncotarget.18049. eCollection 2017 Sep 22.
7
Novel markers for circulating tumor stem cells in colorectal carcinoma.
Am J Transl Res. 2016 Oct 15;8(10):4233-4241. eCollection 2016.
8
Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.
Tumour Biol. 2015 Jul;36(7):5353-60. doi: 10.1007/s13277-015-3196-6. Epub 2015 Feb 12.
本文引用的文献
1
Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study.
Ann Surg. 2011 Oct;254(4):569-76. doi: 10.1097/SLA.0b013e3182300a1d.
2
Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.
J Clin Oncol. 2011 Apr 20;29(12):1508-11. doi: 10.1200/JCO.2010.34.0026. Epub 2011 Mar 21.
3
Tumor self-seeding by circulating cancer cells.
Cell. 2009 Dec 24;139(7):1315-26. doi: 10.1016/j.cell.2009.11.025.
4
Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Cancer Lett. 2009 Dec 28;286(2):145-53. doi: 10.1016/j.canlet.2009.04.027. Epub 2009 May 22.
5
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.
Nat Rev Cancer. 2008 Oct;8(10):755-68. doi: 10.1038/nrc2499. Epub 2008 Sep 11.
6
The epithelial-mesenchymal transition generates cells with properties of stem cells.
Cell. 2008 May 16;133(4):704-15. doi: 10.1016/j.cell.2008.03.027.
7
Mechanisms of Disease: cancer stem cells--targeting the evil twin.
Nat Clin Pract Oncol. 2008 Jun;5(6):337-47. doi: 10.1038/ncponc1110. Epub 2008 Apr 22.
8
Detection, clinical relevance and specific biological properties of disseminating tumour cells.
Nat Rev Cancer. 2008 May;8(5):329-40. doi: 10.1038/nrc2375.
9
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Cancer Res. 2008 Mar 1;68(5):1451-61. doi: 10.1158/0008-5472.CAN-07-6013.
10
Identification of local and circulating cancer stem cells in human liver cancer.
Hepatology. 2008 Mar;47(3):919-28. doi: 10.1002/hep.22082.
Zotero 插件